Changing Landscape of Treatment Options for Metastatic Urothelial Carcinoma – Enduring Webcast

Description

Program Description

---

This webcast is intended to improve care of patients with urothelial carcinoma by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.

Intended Audience

---

This webcast is designed to meet the educational needs of medical oncologists, urologists, radiation oncologists, nurse practitioners, physician assistants, nurses, and pharmacists who diagnose, treat, and manage patients with urothelial carcinoma.

Commercial Supporter

---

Supported by Astellas and Seattle Genetics